Positive Results for Edoxaban in VTE/PE
Findings from the Hokusai-VTE trial of edoxabanThe post Positive Results for Edoxaban in VTE/PE appeared first on CardioExchange.
View ArticleIs Edoxaban the Most Promising of the Novel Anticoagulants?
Samuel Z. Goldhaber offers his perspective on the Hokusai-VTE randomized trial comparing edoxaban and warfarin in patients with symptomatic venous thromboembolism. The post Is Edoxaban the Most...
View ArticleIs It Safe to Treat Acute Pulmonary Embolism in an Outpatient Setting?
Christopher Kabrhel discusses his research group’s study of the factors associated with clinical deterioration and the need for hospital-based interventions after an acute pulmonary embolism. The post...
View ArticleNew Trial Confirms Role for Dabigatran in Venous Thromboembolism
A new study helps support a role for the new oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim) in patients with venous thrombosis (VTE). The RE-COVER II trial, published online in...
View ArticleVena Cava Filters Reduce Pulmonary Emboli But Increase VTE Recurrence Tenfold
Inferior vena cava filters seem to offer protection against death from pulmonary embolism when compared with anticoagulant therapy, but they have no significant effect on all-cause mortality. In...
View ArticlePulmonary Embolism in a Patient with Acute Decompensated Systolic Heart Failure
Ian Neeland presents our latest case: A 42-year-old man with heart failure is found to have a large pulmonary embolus. Tell us how you'd manage his treatment. The post Pulmonary Embolism in a Patient...
View ArticleSelections from Richard Lehman’s Literature Review: March 24th
This week's topics include non-leg venous thrombosis in critically ill adults, a comparison of factor Xa inhibitors and warfarin for preventing stroke and thromboembolism in atrial fibrillation, and...
View ArticleSelections from Richard Lehman’s Literature Review: April 14th
This week's topics include TOPCAT, fibrinolysis for those with intermediate-risk PE, and more.The post Selections from Richard Lehman’s Literature Review: April 14th appeared first on CardioExchange.
View ArticleMixed Results for Thrombolysis in Pulmonary Embolism
The role of thrombolytic therapy for the treatment of pulmonary embolism has been unclear, as it has been difficult to measure the precise balance between enhanced clot-dissolving efficacy and...
View ArticleA Meta-Look at Thrombolysis vs. Conventional Anticoagulation for PE
Jay Giri and Saurav Chatterjee discuss their meta-analysis of trials comparing thrombolytic therapy and conventional anticoagulation in patients at intermediate risk for pulmonary embolism. The post A...
View Article
